Results for "Specialty Pharmaceutical Distribution Facts, Figures, and Trends"
Chip Davis Shares HDA’s 2025 Policy Priorities in Annual Chain Drug Review Column
In his annual “Health Care Outlook” column featured in Chain Drug Review, HDA’s President and CEO Chip Davis outlines a series of key policy priorities for healthcare distributors in 2025, as well as some challenges he expects the industry to face.
Healthcare Distributors Are Supporting Under-Resourced Communities During COVID-19
On October 7, HDA launched a three-part series to showcase how the distribution industry is helping create healthier communities through philanthropy, employee activism, partnerships with nonprofit organizations and more. This week, we are sharing how HDA distributors have acted with urgency to meet the unprecedented needs of Americans, and individuals across the globe, during the COVID-19 pandemic.
Honoring Black History: February and Year-Round
With February’s Black History Month coming to a close, HDA and our members are committed to continuing to celebrate the contributions of Black and African Americans throughout history and across the country. Though the month marks a vital and designated occasion, our members and association work year-round to promote an industry culture that welcomes and celebrates the contributions of individuals from these communities and others as we strengthen the sense of belonging across the distribution sector. This blog summarizes some of the ways our sector has acknowledged Black and African American history, during this month and beyond.